Portuguese
Albanian
Arabic
Armenian
Azerbaijani
Belarusian
Bengali
Bosnian
Catalan
Czech
Danish
Deutsch
Dutch
English
Estonian
Finnish
Français
Greek
Haitian Creole
Hebrew
Hindi
Hungarian
Icelandic
Indonesian
Irish
Italian
Japanese
Korean
Latvian
Lithuanian
Macedonian
Mongolian
Norwegian
Persian
Polish
Portuguese
Romanian
Russian
Serbian
Slovak
Slovenian
Spanish
Swahili
Swedish
Turkish
Ukrainian
Vietnamese
Български
中文(简体)
中文(繁體)

Obex, a Nutritional Supplement, in Overweight and Obese Spanish Women

Apenas usuários registrados podem traduzir artigos
Entrar Inscrever-se
O link é salvo na área de transferência
StatusConcluído
Patrocinadores
Catalysis SL

Palavras-chave

Resumo

The aim of the study is to evaluate the effects of a dietary supplement (Obex®) on anthropometric and physiological variables in Spanish women between 35 and 60 years who are overweight or obese.

Descrição

The nutritional supplement consists of natural plant extracts such as Caralluma fimbriata, Phaseolus vulgaris, Acai Berry and other antiobesity agents: ornithine, carnitine fumarate, essential fatty acids and certain amino acids, vitamins and minerals.

datas

Última verificação: 01/31/2014
Enviado pela primeira vez: 08/08/2013
Inscrição estimada enviada: 08/28/2013
Postado pela primeira vez: 09/03/2013
Última atualização enviada: 02/23/2014
Última atualização postada: 02/24/2014
Data real de início do estudo: 07/31/2013
Data Estimada de Conclusão Primária: 01/31/2014
Data Estimada de Conclusão do Estudo: 01/31/2014

Condição ou doença

Obesity
Overweight

Intervenção / tratamento

Dietary Supplement: Obex, a nutritional supplement

Drug: Placebo

Fase

Fase 2/Fase 3

Grupos de Armas

BraçoIntervenção / tratamento
Experimental: Obex, a nutritional supplement
Obex will be administered two sachets daily dissolved in a glass of water, 30 minutes before lunch and dinner during two months. Patients will be recommended to comply with a healthy lifestyle through diet and exercise.
Dietary Supplement: Obex, a nutritional supplement
After concluded the two months of treatment, patients will be follow-up during three months without consumption of Obex.
Placebo Comparator: Placebo
Placebo will be administered two sachets daily dissolved in a glass of water, 30 minutes before lunch and dinner during two months. Patients will be recommended to comply with a healthy lifestyle through diet and exercise.
Drug: Placebo
After concluded the two months of treatment, patients will be follow-up during three months without consumption of the placebo.

Critério de eleição

Idades qualificadas para estudar 35 Years Para 35 Years
Sexos elegíveis para estudoFemale
Aceita Voluntários Saudáveissim
Critério

Inclusion Criteria:

- Women aged between 35 and 60 years.

- Body Mass Index (BMI) greater than 27 kg/m² and lower than 35 kg/m²

- Ability to provide informed consent

Exclusion Criteria:

- Presence of any endocrine, hepatic, renal or cardiovascular disease.

- History of bariatric surgery

- Pregnancy or lactation

- Concomitant disease with reduced life expectancy

- Severe psychiatric conditions

- Drug dependence

Resultado

Medidas de Resultado Primário

1. To evaluate the effect of OBEX on skinfolds [Two months of treatment and three months after concluded the treatment]

The primary outcome is to evaluate the effect of the treatment with OBEX on skinfold thickness of the biceps, triceps, subscapular and suprailiac as compared to placebo group at 2 months of treatment.

Medidas de Resultado Secundário

1. To evaluate the effect of OBEX on the waist and hip circumferences [Two months of treatment and three months after concluded the treatment]

Waist and Hip circumferences will be measured at baseline and at the end of treatment.

2. To evaluate the effect of Obex on the arm circumference. [Two months of treatment and three months after concluded the treatment]

The arm circumference will be measured at baseline and at the end of treatment.

3. To evaluate the effect of Obex on the percentage of body fat [Two months of treatment and three months after concluded the treatment]

Body fat (%) will be assessed at baseline and the end of treatment

4. To evaluate the effect of Obex on the muscular mass [Two months of treatments and three months after concluded the treatment]

The muscular mass will be measured at baseline and at the end of treatment.

5. To evaluate the effect of Obex on arterial blood pressures. [Two months of treatment and three months after concluded the treatment]

The arterial BP will be evaluated at baseline and at the end of treatment.

6. To evaluate the effect of Obex on fasting glucose and cholesterol levels [Two months of treatment and three months after concluded the treatment]

The fasting glucose and cholesterol levels will be evaluated at baseline and at the end of treatment.

Junte-se à nossa
página do facebook

O mais completo banco de dados de ervas medicinais apoiado pela ciência

  • Funciona em 55 idiomas
  • Curas herbais apoiadas pela ciência
  • Reconhecimento de ervas por imagem
  • Mapa GPS interativo - marcar ervas no local (em breve)
  • Leia publicações científicas relacionadas à sua pesquisa
  • Pesquise ervas medicinais por seus efeitos
  • Organize seus interesses e mantenha-se atualizado com as notícias de pesquisa, testes clínicos e patentes

Digite um sintoma ou doença e leia sobre ervas que podem ajudar, digite uma erva e veja as doenças e sintomas contra os quais ela é usada.
* Todas as informações são baseadas em pesquisas científicas publicadas

Google Play badgeApp Store badge